reviewArchives of Pharmacal ResearchMay 1, 2025HYBRID OA

Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance

Chosun University · Kyung Hee University

PubMed
Indexed incrossrefpubmed

Abstract

Angiogenesis, the process of new blood vessel formation, is a fundamental physiological process implicated in several pathological disorders. The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are crucial for angiogenesis and vasculogenesis. Among them, the tyrosine kinase receptor VEGFR-2 is primarily expressed in endothelial cells (ECs). These cells regulate various physiological responses, including differentiation, cell proliferation, migration, and survival, by binding to VEGF mitogens. Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) is a key regulator of this process, making it a prime target for therapeutic intervention. Several drugs targeting VEGFR-2 have been…

Citation impact

56
total citations
FWCI
34.94
Percentile
100%
References
156
Citations per year

Authors

7

Topics & keywords

Keywords
  • Angiogenesis
  • Vasculogenesis
  • Cell biology
  • Cancer research
  • Vascular endothelial growth factor
  • Kinase insert domain receptor
  • Regulator
  • Receptor tyrosine kinase
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding